3D Medicines Inc. (01244) Announces No Change in Share Capital for October 2025
Bulletin Express
Nov 05
3D Medicines Inc. (01244) reported that, as of 31 October 2025, its authorized share capital remained at 500,000,000 ordinary shares with a par value of HKD 0.001 each, totaling HKD 500,000. The total number of issued shares stood at 258,177,000, with no changes observed during the month.
Under its share option scheme, 12,802,850 outstanding share options remained unchanged, with no new shares issued or treasury shares transferred. Consequently, there was no impact on issued share capital for the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.